The FDA approved pirtobrutinib for adults with either chronic lymphocytic leukemia or small lymphocytic lymphoma who have received at least two prior lines of therapy.
Researchers examined the impact of protein-energy malnutrition on the risk of death in patients with diffuse large B-cell lymphoma who are undergoing chemotherapy.
The risk of lymphoma has been reported to be higher among patients with IBD receiving thiopurines. In a recent study, researchers sought to further investigate this risk among patients with IBD with various...
The US Food and Drug Administration has approved a combination intravenous treatment for follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia.
The FDA has posted a correction for this press release: "The notice posted to the Hematology/Oncology Approvals web page yesterday afternoon regarding an approval for the treatment of Hodgkin lymphoma...
New research investigated whether chronic hepatitis B or C virus infection were associated with increased incidence of non-Hodgkin lymphoma in patients also infected with human immunodeficiency virus...
